Constrictive Pericarditis: When Heart Failure Is Not the Heart — CT, Echocardiography, MRI, and AI-Assisted Diagnosis

A Case Where the Heart Appears to Fail, but the Myocardium Is Not the Problem

Heart failure is usually approached as a problem of the heart muscle.

Reduced contractility, myocardial ischemia, cardiomyopathy, valvular disease, rhythm disturbance, and other cardiac disorders are common explanations for progressive dyspnea, peripheral edema, elevated jugular venous pressure, and exercise intolerance.

But there is another possibility.

The myocardium may be relatively preserved while the heart is mechanically trapped by an abnormal pericardium.

This is the central diagnostic challenge of constrictive pericarditis.

In this condition, chronic inflammation and fibrosis can transform the pericardium into a rigid structure that restricts normal diastolic filling. The resulting physiology can resemble congestive heart failure even though the fundamental problem is not primary myocardial failure.

This distinction matters because constrictive pericarditis can be potentially treatable, and the diagnostic pathway is fundamentally different from routine management of myocardial heart failure.

The case considered here illustrates an important principle in modern medical imaging:

When the clinical syndrome says “heart failure,” imaging must still ask whether the heart muscle is actually failing.


The Clinical Presentation: Heart Failure Without an Obvious Myocardial Explanation

A man in his late 60s presented with progressive cardiopulmonary symptoms characterized by:

  • Progressive dyspnea
  • Severe lower-extremity edema
  • Jugular venous distention
  • Kussmaul sign
  • Persistent symptoms despite repeated heart failure treatment

These findings strongly suggest elevated systemic venous pressure and impaired cardiac filling.

The difficulty is that the clinical phenotype does not immediately identify the mechanism.

The patient can appear to have conventional congestive heart failure while the underlying physiology is actually constrictive pericardial disease.

This is one of the reasons constrictive pericarditis may remain diagnostically challenging.

The differential diagnosis may include:

  • Heart failure with preserved ejection fraction
  • Restrictive cardiomyopathy
  • Severe tricuspid regurgitation
  • Right ventricular dysfunction
  • Pulmonary hypertension
  • Hepatic disease with volume overload
  • Chronic pericardial disease
  • Constrictive pericarditis

The critical question is therefore not simply:

“Does this patient have heart failure?”

The more important question is:

“Why is the heart failing to fill normally?”

That change in diagnostic thinking is where medical imaging becomes decisive.


What Is Constrictive Pericarditis?

Figure 1. Lateral chest radiograph showing extensive pericardial calcification

The pericardium is normally a thin, compliant structure surrounding the heart.

In constrictive pericarditis, chronic inflammation may lead to:

  1. Pericardial fibrosis
  2. Pericardial thickening
  3. Adhesion between pericardial layers
  4. Calcification
  5. Loss of normal pericardial compliance
  6. Restriction of ventricular filling

The result is a mechanical limitation on cardiac expansion during diastole.

The myocardium may initially maintain relatively preserved systolic function, but the ventricles cannot expand normally because the surrounding pericardial envelope has become rigid.

This creates an important physiological phenomenon:

ventricular interdependence.

Because the total volume available inside the rigid pericardial compartment is constrained, increased filling of one ventricle can occur at the expense of filling of the other.

This interaction becomes particularly important during respiration.

Consequently, constrictive pericarditis is not simply a disease that can be diagnosed by looking for a thickened pericardium.

It is a disease of pericardial anatomy plus cardiac physiology.


Chest X-Ray: The First Clue May Be Calcification

Chest radiography remains relevant even in an era dominated by CT and MRI.

In the appropriate clinical context, extensive pericardial calcification can be an important clue to chronic pericardial disease.

The radiographic finding itself, however, should not be interpreted in isolation.

Pericardial calcification supports the possibility of chronic constrictive disease, but the absence of calcification does not exclude constriction.

This is a critical point for radiology interpretation.

A normal or non-calcified pericardium on chest radiography should not prematurely terminate the diagnostic process when the clinical and physiological findings remain suspicious.

The role of the chest radiograph is therefore best understood as:

a clue-generating examination rather than a definitive test.


CT: The Anatomical Map of the Pericardium

Figure 2. Axial chest CT demonstrating bilateral pleural effusion

Computed tomography provides a major advantage because it depicts the pericardium with high spatial resolution.

In the present case, CT demonstrated:

  • Pericardial thickening of approximately 6 mm
  • Extensive pericardial calcification
  • Pleural effusion

These findings substantially strengthen the suspicion for chronic constrictive pericardial disease.

CT can answer several important anatomical questions:

1. Is the pericardium thickened?

Pericardial thickening supports chronic pericardial disease, although thickness alone does not prove physiological constriction.

2. Is there pericardial calcification?

Calcification can indicate chronicity and is particularly useful when it is extensive.

3. Is the abnormality diffuse or focal?

Localized constriction may be overlooked if the radiologist evaluates only a limited portion of the pericardium.

4. Is there associated pleural or pulmonary disease?

Pleural effusion and other thoracic findings may provide additional evidence of chronic hemodynamic consequences.

5. Is there an alternative explanation?

CT can simultaneously evaluate the lungs, mediastinum, great vessels, and other thoracic structures.

This makes cardiac CT particularly valuable when the clinical question involves both anatomy and differential diagnosis.

However, one important principle must be emphasized:

A thick pericardium is not synonymous with constrictive physiology.

Conversely, constriction can occasionally occur without dramatic pericardial thickening.

Therefore, CT should be integrated with echocardiographic and clinical findings rather than interpreted as a stand-alone diagnostic endpoint.


Echocardiography: Seeing the Physiology

If CT shows the structural envelope, echocardiography helps reveal what that envelope is doing to the heart.

This distinction is fundamental.

Constrictive pericarditis is a physiological disorder, and echocardiography can directly evaluate the consequences of the abnormal pericardium on ventricular filling.

Important echocardiographic findings include:

  • Respiration-related ventricular septal shift
  • Ventricular interdependence
  • Abnormal mitral inflow respiratory variation
  • Preserved or increased medial mitral annular e′ velocity
  • Hepatic vein expiratory diastolic flow reversal

The septal bounce described in this case is therefore more than a visually interesting sign.

It reflects abnormal ventricular interaction produced by the constraining pericardium.

The Mayo Clinic echocardiographic criteria emphasize the importance of respiration-related septal shift, medial mitral annular e′ velocity, and hepatic vein expiratory diastolic flow reversal in distinguishing constrictive pericarditis from restrictive myocardial disease and other mimics.

This is why echocardiography should not be reduced to a simple measurement of ejection fraction.

A patient can have a relatively preserved ejection fraction and still have severe cardiac dysfunction caused by abnormal diastolic mechanics.


Cardiac MRI: Anatomy, Physiology, and Tissue Characterization

Cardiac MRI provides another layer of diagnostic information.

The value of cardiac MRI in constrictive pericarditis lies not merely in measuring pericardial thickness.

It can provide:

  • High-resolution pericardial anatomy
  • Assessment of ventricular motion
  • Evaluation of ventricular interdependence
  • Tissue characterization
  • Detection of pericardial inflammation
  • Assessment of myocardial involvement
  • Better differentiation of active inflammation from chronic fibrotic disease

This becomes particularly important when clinicians need to determine whether constriction is associated with active inflammation.

The distinction has therapeutic implications.

A patient with potentially reversible inflammatory constriction may have a different management pathway from a patient with established chronic fibrotic constriction.

MRI therefore becomes more than another imaging examination.

It can help answer a clinically meaningful question:

Is the abnormal pericardium merely thickened, or is there active inflammatory disease that may still be biologically modifiable?

Modern guidelines emphasize multimodality imaging for suspected constrictive pericarditis, with CT and cardiovascular MRI providing complementary structural and tissue information.


Why CT and MRI Should Not Be Viewed as Competing Tests

One common mistake is to ask:

“Should we perform CT or MRI?”

The better question is:

“What clinical question does each modality answer?”


Table 1. Multimodality Imaging Roles in Constrictive Pericarditis

ModalityKey FindingDiagnostic Role
Chest X-rayPericardial calcificationInitial clue
CTPericardial thickening/calcificationAnatomical assessment
EchocardiographySeptal bounce, ventricular interdependencePhysiological assessment
Cardiac MRIInflammation, fibrosis, ventricular interactionTissue characterization

This complementary strategy is the foundation of modern cardiac imaging.

The modalities are not redundant.

They interrogate different dimensions of the disease.

X-ray sees the clue.
CT defines the structure.
Echocardiography demonstrates the physiology.
MRI adds tissue characterization and functional context.

That is the essence of multimodality imaging.


The Most Important Differential Diagnosis: Constriction vs Restriction

One of the most important diagnostic challenges is differentiating constrictive pericarditis from restrictive cardiomyopathy.

Both conditions can produce:

  • Elevated venous pressure
  • Peripheral edema
  • Dyspnea
  • Diastolic dysfunction
  • Exercise intolerance
  • Preserved or relatively preserved systolic function

But their anatomical origins are different.


Table 2. Constrictive Pericarditis vs. Restrictive Cardiomyopathy

FeatureConstrictive PericarditisRestrictive Cardiomyopathy
Primary sitePericardiumMyocardium
Pericardial thickeningMay be presentUsually absent
CalcificationMay be prominentNot typical
Ventricular interdependenceProminentLess characteristic
Septal bounceCommonNot typical
MRI rolePericardial/tissue assessmentMyocardial characterization

Constrictive Pericarditis

The primary abnormality is the pericardium.

The rigid pericardial envelope limits cardiac expansion.

Restrictive Cardiomyopathy

The primary abnormality is the myocardium.

Myocardial infiltration, fibrosis, or other structural abnormalities impair ventricular relaxation and filling.

This distinction has major therapeutic implications.

A patient with constrictive pericarditis may be evaluated for pericardiectomy when permanent constriction is established and clinically significant.

A patient with restrictive cardiomyopathy requires an entirely different diagnostic and therapeutic strategy.

Therefore:

The distinction between constriction and restriction is not academic. It can change the entire clinical pathway.


Where Artificial Intelligence Can Help

Artificial intelligence is increasingly being integrated into medical imaging workflows.

However, the most clinically responsible way to discuss AI in constrictive pericarditis is not to claim that an algorithm independently diagnoses the disease.

The more realistic model is AI-assisted multimodality decision support.

Potential applications include:

Table 3. Potential Roles of AI in Constrictive Pericarditis Imaging

AI FunctionPotential ApplicationHuman Role
DetectionPericardial calcification/thickeningRadiologist verification
QuantificationPericardial and cardiac measurementsClinical interpretation
WorkflowPrioritization and triageFinal responsibility
Decision SupportMultimodality pattern integrationMultidisciplinary decision

Automated Pericardial Abnormality Detection

Computer vision algorithms could identify:

  • Pericardial calcification
  • Pericardial thickening
  • Pericardial effusion
  • Abnormal cardiac contours

on CT examinations.

Quantitative Imaging

AI may assist in measuring:

  • Pericardial thickness
  • Calcification burden
  • Cardiac chamber dimensions
  • Ventricular volumes
  • Temporal changes between examinations

Quantitative analysis may improve reproducibility compared with purely qualitative assessment.

Echocardiographic Analysis

AI-assisted echocardiography may help quantify:

  • Septal motion
  • Respiratory variation
  • Doppler parameters
  • Myocardial velocities
  • Chamber volumes

The challenge is that constrictive physiology is highly dependent on acquisition quality and clinical context.

An algorithm that detects an abnormal septal movement is not automatically proving constrictive pericarditis.

Multimodal Clinical Decision Support

The most interesting future application may be integration.

An AI platform could potentially combine:

CT + echocardiography + cardiac MRI + clinical history + laboratory data + prior imaging

to generate a structured diagnostic alert.

For example:

Pattern Suggestive of Constrictive Pericardial Disease

Possible supporting features:

  • Pericardial calcification
  • Pericardial thickening
  • Septal bounce
  • Ventricular interdependence
  • Abnormal respiratory Doppler findings
  • MRI evidence of pericardial inflammation or fibrosis

The final interpretation, however, should remain with the appropriately trained clinical team.


AI Should Support Radiologists, Not Replace Them

This case also demonstrates an important principle in clinical AI.

A medical AI system may recognize patterns, but the radiologist must determine whether those patterns make clinical sense.

For example, pericardial thickening can occur in conditions that do not necessarily produce constrictive physiology.

Similarly, calcification does not by itself establish the diagnosis.

AI may identify the abnormality.

The radiologist must determine its significance.

The cardiologist must integrate the hemodynamics.

The cardiac surgeon must determine procedural feasibility.

The clinical team must determine the final management strategy.

This is why the future of medical imaging is unlikely to be:

AI versus physician.

It is much more likely to be:

AI + radiologist + cardiologist + surgeon + clinical data.


The Hidden Cost of Diagnostic Delay

The economic dimension of constrictive pericarditis is important, but it should be approached carefully.

Healthcare costs vary substantially according to country, insurance system, hospital, inpatient versus outpatient status, procedure complexity, and local reimbursement.

Therefore, a single universal dollar value for “the cost of constrictive pericarditis” is misleading.

The more useful concept is diagnostic pathway cost.

When the underlying diagnosis is missed, patients may experience:

  • Repeated emergency visits
  • Recurrent hospitalization
  • Repeated imaging
  • Long-term medication without correction of the underlying mechanism
  • Delayed specialist referral
  • Delayed surgical evaluation
  • Progressive functional deterioration

The financial burden is therefore not simply the price of one MRI examination.

It is the cumulative cost of an inefficient diagnostic pathway.

This leads to a broader healthcare principle:

The cheapest diagnostic test is not always the lowest-cost clinical strategy.

A relatively expensive imaging examination may reduce downstream costs if it changes the diagnosis and prevents months of ineffective treatment.

Conversely, inexpensive testing performed repeatedly without resolving the underlying diagnostic question may become expensive over time.


Choosing the Right Hospital Can Become Part of the Diagnosis

Constrictive pericarditis is also an example of why healthcare quality cannot be evaluated solely by individual technologies.

A hospital may have CT.

Another may have cardiac MRI.

Another may have advanced echocardiography.

But the important question is whether the institution can connect these capabilities into an effective clinical pathway.

For complex constrictive pericarditis, important institutional capabilities may include:

  • Advanced echocardiography
  • Cardiac CT
  • Cardiac MRI
  • Experienced cardiovascular radiologists
  • Cardiologists familiar with pericardial disease
  • Cardiac surgery
  • Multidisciplinary case conferences
  • Appropriate hemodynamic assessment
  • Postoperative management capabilities

In other words:

Having the technology is not the same as having the diagnostic system.

A hospital can own an MRI scanner and still lack an effective pathway for recognizing constrictive physiology.

The value of technology emerges only when it is connected to clinical expertise and workflow.


The Modern Diagnostic Workflow

A practical multimodality pathway can be conceptualized as follows:

Step 1 — Recognize the Clinical Pattern

Consider constrictive pericarditis when there is unexplained systemic venous congestion, edema, dyspnea, elevated jugular venous pressure, or Kussmaul sign.

Step 2 — Perform Echocardiography

Evaluate ventricular interaction, septal motion, respiratory variation, tissue Doppler findings, and hepatic venous flow.

Step 3 — Perform CT When Anatomical Definition Is Required

Assess pericardial thickening, calcification, distribution, associated effusion, and other thoracic abnormalities.

Step 4 — Use Cardiac MRI When Tissue Characterization or Functional Clarification Is Needed

Evaluate inflammation, fibrosis, myocardial involvement, ventricular interaction, and other relevant findings.

Step 5 — Resolve Discordant Findings

If clinical findings and noninvasive imaging remain discordant or inconclusive, invasive hemodynamic assessment may become appropriate.

Step 6 — Determine Reversibility and Treatment Pathway

Active inflammatory constriction and established permanent constriction should not automatically be treated as the same biological condition.

Step 7 — Refer to an Experienced Multidisciplinary Center

When surgery or advanced cardiac management is being considered, institutional experience becomes clinically relevant.


What the Radiologist Should Look For

For practical radiology interpretation, a structured approach is useful.

When reviewing CT in a patient with suspected constrictive pericarditis, ask:

Pericardium

  • Is the pericardium thickened?
  • Is the thickening diffuse or focal?
  • Is there calcification?
  • Is the calcification extensive?
  • Is there enhancement suggesting inflammatory activity?
  • Is there an associated pericardial effusion?

Heart

  • Is there abnormal ventricular morphology?
  • Is there evidence of right-sided pressure elevation?
  • Is there abnormal chamber interaction?

Pleura and Lungs

  • Is there pleural effusion?
  • Is there pulmonary edema?
  • Are there alternative pulmonary causes of dyspnea?

Clinical Correlation

  • Does echocardiography demonstrate constrictive physiology?
  • Is there evidence of restrictive cardiomyopathy?
  • Does MRI suggest active inflammation?
  • Is there a history of previous pericardial disease, surgery, radiation, infection, or other relevant causes?

This systematic approach prevents the interpretation from becoming overly dependent on a single imaging sign.


Clinical Pearls

Pearl 1

Not every patient with heart failure symptoms has primary myocardial failure.

Pearl 2

Pericardial calcification is an important clue but does not establish constrictive physiology by itself.

Pearl 3

Pericardial thickening supports the diagnosis but is not sufficient on its own.

Pearl 4

Echocardiography is essential because constrictive pericarditis is fundamentally a physiological disorder.

Pearl 5

Cardiac MRI can provide important information about tissue characteristics, inflammation, and ventricular interaction.

Pearl 6

Constrictive pericarditis and restrictive cardiomyopathy can look clinically similar but require fundamentally different diagnostic strategies.

Pearl 7

AI should be used to augment detection, quantification, workflow, and decision support—not to replace expert clinical interpretation.

Pearl 8

The value of advanced imaging is determined by whether it changes the diagnostic pathway.


The Larger Lesson: Imaging Is Not Just About Finding Abnormalities

The most important lesson from this case extends beyond constrictive pericarditis.

Modern medical imaging is moving from a model of:

“Find the abnormality.”

toward:

“Explain the physiology, quantify the disease, integrate the evidence, and change the decision.”

That evolution is particularly important in cardiovascular imaging.

CT provides anatomy.

Echocardiography provides dynamic physiology.

MRI provides tissue characterization and functional information.

Artificial intelligence can potentially connect these sources of information.

But the final value comes from clinical reasoning.

A sophisticated algorithm cannot compensate for an incorrectly framed clinical question.

Likewise, a high-end MRI scanner cannot help if the patient is never referred for appropriate imaging.

The real innovation is therefore not simply the acquisition of more images.

It is the construction of a diagnostic ecosystem in which imaging, AI, clinical expertise, and healthcare workflow work together.


Conclusion: The Heart May Not Be Failing — It May Be Trapped

Constrictive pericarditis is an important reminder that the appearance of heart failure does not always mean that the myocardium is the primary problem.

A patient may have:

  • Severe edema
  • Elevated jugular venous pressure
  • Dyspnea
  • Kussmaul sign
  • Recurrent congestion

while the central pathology lies outside the myocardium.

In such cases, multimodality imaging becomes decisive.

Chest X-ray may reveal the first clue.

CT defines the pericardial anatomy.

Echocardiography demonstrates constrictive physiology.

Cardiac MRI provides tissue and functional characterization.

AI can potentially accelerate detection, quantification, and workflow integration.

But none of these technologies should be interpreted in isolation.

The diagnosis emerges from the combination of anatomy, physiology, tissue characterization, clinical context, and expert judgment.

That is the real lesson of constrictive pericarditis.

The heart may appear to be failing.

But sometimes the myocardium is not the problem.

The heart is simply trapped.


Key Takeaways for Medical Imaging and Clinical AI

  1. Constrictive pericarditis can mimic conventional heart failure.
  2. Preserved myocardial function does not exclude severe cardiac dysfunction.
  3. Pericardial calcification and thickening are important CT findings.
  4. Echocardiography is critical for demonstrating constrictive physiology.
  5. Cardiac MRI adds tissue characterization and functional information.
  6. CT, echocardiography, and MRI should be viewed as complementary rather than competing modalities.
  7. Restrictive cardiomyopathy remains an important differential diagnosis.
  8. Multimodality imaging is central to contemporary evaluation of suspected constrictive pericarditis.
  9. AI may support detection, quantification, prioritization, and clinical decision support.
  10. AI should augment—not replace—radiologists, cardiologists, and multidisciplinary clinical judgment.
  11. Diagnostic delay can create substantial clinical and healthcare-system costs.
  12. Advanced imaging is valuable when it changes the diagnostic and treatment pathway.

References

[1] J. Schulz-Menger et al., “2025 ESC Guidelines for the management of myocarditis and pericarditis,” European Heart Journal, vol. 46, no. 40, pp. 3952–4041, 2025, doi: 10.1093/eurheartj/ehaf192.

[2] B. Cosyns et al., “European Association of Cardiovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease,” European Heart Journal–Cardiovascular Imaging, vol. 16, no. 1, pp. 12–31, 2015, doi: 10.1093/ehjci/jeu128.

[3] T. D. Welch et al., “Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria,” Circulation: Cardiovascular Imaging, vol. 7, no. 3, pp. 526–534, 2014, doi: 10.1161/CIRCIMAGING.113.001613.

[4] N. S. Anavekar et al., “Index of biventricular interdependence calculated using cardiac MRI: A proof of concept study in patients with and without constrictive pericarditis,” International Journal of Cardiovascular Imaging, vol. 29, no. 2, pp. 363–369, 2013, doi: 10.1007/s10554-012-0101-x.

[5] R. R. Brandt and J. K. Oh, “Constrictive pericarditis: Role of echocardiography and magnetic resonance imaging,” European Society of Cardiology e-Journal of Cardiology Practice, 2018.

[6] M. J. Pennell et al., “ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance,” Circulation, vol. 121, 2010, including the section on pericardial disease and constrictive pericarditis.

[7] European Society of Cardiology, “2025 ESC Guidelines for the management of myocarditis and pericarditis,” ESC Clinical Practice Guidelines, 2025.


Medical Imaging Insight

The most dangerous diagnostic error in constrictive pericarditis is not failure to recognize a rare disease.

It is assuming that every patient who looks like heart failure has myocardial failure.

When the clinical syndrome and myocardial function do not fit together, look beyond the myocardium.

That is where multimodality imaging can change the diagnosis—and potentially change the patient's entire treatment pathway.

댓글

인기 글

수면 건강 혁신: 기능성 직물 전도성 전극을 활용한 심전도 측정 기술의 최신 연구와 발전 방향

[유방암 영상의학] DCIS 업스테이징 예측을 위한 맘모그래피 기반 Radiomics: 최신 연구로 본 임상적 적용 가능성

최첨단 진단 기술: 악성 포도막 흑색종 전이의 F-18 FDG PET/CT 조기 발견과 생존율 향상 전략

[혁신 의료] 만성폐쇄성폐질환(COPD) 진단의 새로운 패러다임: 동적 흉부 방사선 촬영(DCR)의 효능과 전망

최첨단 하이드로겔 드레싱: 화상 치료와 피부 재생의 혁신, 알지네이트 분사형 드레싱 기술 분석